It is well recognized that tumor cells may induce T cells to differentiate into inhibitory T cells such as Tregs by secreting IL-10 via exogenous regulatory pathways, and/or promote T cells to express inhibitory receptors such as programmed cell death-1 (PD-1) via endogenous pathways [11, 12]. The gene discussed is PDCD1; the disease is neoplasm.